Brind.
  1. FDA is the source of guidance for U.S. healthcare providers.
  2. Eli Lilly and Company operates consistent with guidance provided by the FDA.
  3. Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval.
  4. Eli Lilly is seeking FDA approval for Zepbound and Mounjaro, tied to a $4 billion production site expansion in Kenosha, Wisconsin.

The Food and Drug Administration approved Mounjaro, a drug developed by Eli Lilly and Company.

8 reports, 5 independent Updated Sep 15
Gone quiet
Reports
8
Developments
2
Repetition
75%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 5 independent outlets

The Food and Drug Administration approved Mounjaro, a drug developed by Eli Lilly and Company.

Who's involved

What this event is mainly about
Food and Drug AdministrationEli Lilly and Company

How it developed

Newest first. Tap a step to see who reported it.
  1. FDA granted Mounjaro clearance specifically for cardiovascular risk reduction.1 source
  2. FDA grants approval for Eli Lilly's Mounjaro.1 source

Keep exploring

Part of

Eli Lilly is seeking FDA approval for Zepbound and Mounjaro, tied to a $4 billion production site expansion in Kenosha, Wisconsin. All 1 developments

Within FDA is the source of guidance for U.S. healthcare providers.

The entities involved

Coverage

Newest first; wire copies grouped
2 more outlets ran the same wire story